Back
Cara Therapeutics Stock Price Chart
Sponsored
CARA
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
CARA
Cara Therapeutics
Last Price:
0.31
Seasonality Move:
-4.11%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CARA is experiencing slight buying pressure.
Cara Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.31 | Sell |
20-day SMA: | 0.31 | Buy |
50-day SMA: | 0.29 | Buy |
200-day SMA: | 0.51 | Sell |
8-day EMA: | 0.31 | Sell |
20-day EMA: | 0.31 | Buy |
50-day EMA: | 0.31 | Buy |
200-day EMA: | 0.7 | Sell |
Cara Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 53.09 | Buy |
Chaikin Money Flow: | 57374 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.27 - 0.33) | Buy |
Bollinger Bands (100): | (0.27 - 0.35) | Sell |
Cara Therapeutics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cara Therapeutics Stock
Is Cara Therapeutics Stock a Buy?
- Cara Therapeutics share price is 0.31 while CARA 8-day simple moving average is 0.31, which is a Sell signal.
- The stock price of CARA is 0.31 while Cara Therapeutics 20-day SMA is 0.31, which makes it a Buy.
- Cara Therapeutics 50-day simple moving average is 0.29 while CARA share price is 0.31, making it a Buy technically.
- CARA stock price is 0.31 and Cara Therapeutics 200-day simple moving average is 0.51, creating a Sell signal.
CARA Technical Analysis vs Fundamental Analysis
Sell
20
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics a Buy or a Sell?
-
Cara Therapeutics stock is rated a Sell
The current Cara Therapeutics [CARA] share price is $0.31. The Score for CARA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Cara Therapeutics Stock Info
Market Cap:
17.01M
Price in USD:
0.31
Share Volume:
172.12K
Cara Therapeutics 52-Week Range
52-Week High:
1.31
52-Week Low:
0.24
Sell
20
Cara Therapeutics (CARA)
is a Sell
Cara Therapeutics Share Price Forecast
-
What is the Cara Therapeutics stock price today?
The Cara Therapeutics stock price is 0.31 USD today. -
Will CARA stock go up or go down?
Cara Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cara Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cara Therapeutics is overvalued.
Is Cara Therapeutics Stock a Buy?
- Cara Therapeutics share price is 0.31 while CARA 8-day exponential moving average is 0.31, which is a Sell signal.
- The stock price of CARA is 0.31 while Cara Therapeutics 20-day EMA is 0.31, which makes it a Buy.
- Cara Therapeutics 50-day exponential moving average is 0.31 while CARA share price is 0.31, making it a Buy technically.
- CARA stock price is 0.31 and Cara Therapeutics 200-day simple moving average is 0.70, creating a Sell signal.
Fundamental Analysis of Cara Therapeutics
Is Cara Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.50 per share.
Technical Analysis of Cara Therapeutics
Should I short Cara Therapeutics stock?
- CARA Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Cara Therapeutics is a Buy
- Cara Therapeutics Relative Strength Index (RSI) is 53.09, which suggest Cara Therapeutics is overbought
- The Bollinger Bands (25) for Cara Therapeutics is (0.27 - 0.33), which suggest Cara Therapeutics is a Sell
- The Bollinger Bands (100) for Cara Therapeutics is (0.27 - 0.35), which suggest Cara Therapeutics is a Sell
* Cara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.